Daniel Auclair/X
Jun 16, 2025, 17:37
Daniel Auclair Highlights GMMG-CONCEPT Study Presentation by Lisa Leypoldt at EHA 2025
Daniel Auclair, President at Hematocure, LLC, posted on X:
“Dr. Lisa Leypoldt (congrats again on Young Investigator Award!) presenting GMMG-CONCEPT study, the largest prospective trial so far of purely HR NDMM, at EHA2025.
Isa-KRd induction/consolidation and Isa-KR maint. produced high rates MRDneg and was well tolerated.”
More posts featuring EHA 2025 on Hemostasis Today.
-
Feb 24, 2026, 14:31Augustina Isioma Ikusemoro: What Happens After You Donate Blood?
-
Feb 24, 2026, 14:27Eloïse Laouenan: Rising Risk of Pregnancy Related Venous Thromboembolism
-
Feb 24, 2026, 14:01A European Action Plan on Rare Diseases Is a Necessity, Not an Option – EPODIN
-
Feb 24, 2026, 13:59Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
-
Feb 24, 2026, 13:29Win Ratio Analysis of Edoxaban vs Dalteparin in Cancer-Associated VTE – JTH
-
Feb 24, 2026, 13:28EAHAD Welcomes New Members to the Nurses Committee
-
Feb 24, 2026, 13:25AbQader Bedil: Donor Ferritin Testing and Iron Care
-
Feb 24, 2026, 12:53Tagreed Alkaltham։ Blood Is a Naturally Integrated and Adaptive Physiological System
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH